Skip to main content
Ilaris - Important information for patients with Gouty Arthritis
Patient alert card listing important information to consider before and during treatment with canakinumab for patients with Gouty Arthritis
Back to top
Risk Minimisation Materials
Search by company, common medicine name, or title of Risk Minimisation Material
Ilaris
Novartis Pharmaceuticals UK Ltd
Ilaris - Important information for patients with Period Fever Syndromes
Patient alert card listing important information to consider before and during treatment with canakinumab for patients with Periodic Fever Syndromes CAPS, TRAPS, HIDS/MKD or FMF
Ilaris - Important information for the patient with Still's Disease (including Adult Onset Still's Disease) and Systemic Juvenile Idiopathic Arthritis
Patient alert card listing important information to consider before and during treatment with canakinumab for patients with Still's Disease (including Adult Onset Still's Disease) and Systemic Juvenile Idiopathic Arthritis
You are trying to reach document intended for healthcare professionals only.
Are you a healthcare professional?
